We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
226
Weyerhaeuser
WY
$16.1B
$48.8M 0.12%
1,719,222
+135,036
+9% +$4.18M
TMO icon
227
Thermo Fisher Scientific
TMO
$237B
$48.5M 0.12%
87,752
-3,723
-4% -$2.13M
RZLT icon
228
Rezolute
RZLT
$400M
$48.5M 0.11%
11,279,327
+1,125,000
+11% +$3.87M
EXPE icon
229
Expedia Group
EXPE
$35.2B
$47.3M 0.11%
375,572
-7,253
-2% -$894K
AEM icon
230
Agnico Eagle Mines
AEM
$99.7B
$46.9M 0.11%
717,300
-102,765
-13% -$6.7M
LRCX icon
231
Lam Research
LRCX
$339B
$46.8M 0.11%
439,910
-29,010
-6% -$2.78M
QTWO icon
232
Q2 Holdings
QTWO
$3.75B
$46.5M 0.11%
770,134
+39,406
+5% +$2.26M
SRAD icon
233
Sportradar
SRAD
$3.94B
$46.4M 0.11%
4,152,300
-259,534
-6% -$2.7M
IQV icon
234
IQVIA
IQV
$44.4B
$46.2M 0.11%
218,306
+28,611
+15% +$6.5M
AIT icon
235
Applied Industrial Technologies
AIT
$11.6B
$45.6M 0.11%
234,857
-209
-0.1% -$39.9K
OTIS icon
236
Otis Worldwide
OTIS
$26.1B
$45.5M 0.11%
473,024
+116,646
+33% +$11.2M
FND icon
237
Floor & Decor
FND
$4.91B
$45.5M 0.11%
458,001
-19,509
-4% -$2.24M
MMS icon
238
Maximus
MMS
$3.05B
$45.4M 0.11%
530,117
-16,198
-3% -$1.36M
TOST icon
239
Toast
TOST
$18.4B
$44.6M 0.11%
1,731,600
+124,406
+8% +$3.01M
CEG icon
240
Constellation Energy
CEG
$92.1B
$44.4M 0.11%
221,898
+2,383
+1% +$486K
GS icon
241
Goldman Sachs
GS
$284B
$44M 0.1%
97,369
-16,888
-15% -$7.41M
DYN icon
242
Dyne Therapeutics
DYN
$3.34B
$42.9M 0.1%
1,215,112
+114,888
+10% +$3.34M
KRC icon
243
Kilroy Realty
KRC
$4.01B
$42.9M 0.1%
1,374,826
+50,619
+4% +$1.68M
MSCI icon
244
MSCI
MSCI
$39.6B
$42.7M 0.1%
88,682
-32,881
-27% -$16.3M
PGR icon
245
Progressive
PGR
$129B
$41.9M 0.1%
201,754
+79,303
+65% +$16.6M
PCOR icon
246
Procore
PCOR
$7.99B
$41.8M 0.1%
630,545
+104,179
+20% +$7.23M
ACGL icon
247
Arch Capital
ACGL
$33.1B
$41.6M 0.1%
412,476
+18,161
+5% +$1.77M
BAH icon
248
Booz Allen Hamilton
BAH
$9.63B
$41.3M 0.1%
268,395
+39,023
+17% +$5.85M
CAT icon
249
Caterpillar
CAT
$360B
$41.3M 0.1%
123,947
-17,461
-12% -$6.05M
IDXX icon
250
Idexx Laboratories
IDXX
$40.2B
$41.2M 0.1%
84,641
-21,320
-20% -$10.7M

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.